Acorah Software Products - Accounts Production 16.3.350 false true 30 September 2023 1 October 2022 false 1 October 2023 30 September 2024 30 September 2024 05568247 Mr Adam Gay Mrs Louise Gay iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 05568247 2023-09-30 05568247 2024-09-30 05568247 2023-10-01 2024-09-30 05568247 frs-core:CurrentFinancialInstruments 2024-09-30 05568247 frs-core:ComputerEquipment 2023-10-01 2024-09-30 05568247 frs-core:PlantMachinery 2024-09-30 05568247 frs-core:PlantMachinery 2023-10-01 2024-09-30 05568247 frs-core:PlantMachinery 2023-09-30 05568247 frs-core:ShareCapital 2024-09-30 05568247 frs-core:RetainedEarningsAccumulatedLosses 2024-09-30 05568247 frs-bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 05568247 frs-bus:FilletedAccounts 2023-10-01 2024-09-30 05568247 frs-bus:SmallEntities 2023-10-01 2024-09-30 05568247 frs-bus:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 05568247 frs-bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 05568247 frs-bus:Director1 2023-10-01 2024-09-30 05568247 frs-bus:Director2 2023-10-01 2024-09-30 05568247 frs-countries:EnglandWales 2023-10-01 2024-09-30 05568247 2022-09-30 05568247 2023-09-30 05568247 2022-10-01 2023-09-30 05568247 frs-core:CurrentFinancialInstruments 2023-09-30 05568247 frs-core:ShareCapital 2023-09-30 05568247 frs-core:RetainedEarningsAccumulatedLosses 2023-09-30
Registered number: 05568247
DNA Healthcare Advertising Ltd
Unaudited Financial Statements
For The Year Ended 30 September 2024
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—3
Page 1
Balance Sheet
Registered number: 05568247
2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 272 878
272 878
CURRENT ASSETS
Debtors 5 19,247 6,312
Cash at bank and in hand 209,845 232,744
229,092 239,056
Creditors: Amounts Falling Due Within One Year 6 (135,563 ) (130,864 )
NET CURRENT ASSETS (LIABILITIES) 93,529 108,192
TOTAL ASSETS LESS CURRENT LIABILITIES 93,801 109,070
NET ASSETS 93,801 109,070
CAPITAL AND RESERVES
Called up share capital 100 100
Profit and Loss Account 93,701 108,970
SHAREHOLDERS' FUNDS 93,801 109,070
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Adam Gay
Director
02/06/2025
The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
DNA Healthcare Advertising Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 05568247. The registered office is Upper Ground Floor, Unit 5, Bay 5, 11 Mowll Street, London, SW9 6BG.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover represents net invoiced sales of services, excluding value added tax.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 25% - Straight Line Method
Computer Equipment 25% - Straight Line Method
2.4. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.5. Taxation
Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Taxation assets and liabilities are not discounted.

Tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
2.6. Pensions
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2023: 3)
2 3
4. Tangible Assets
Plant & Machinery etc.
£
Cost
As at 1 October 2023 16,571
As at 30 September 2024 16,571
Depreciation
As at 1 October 2023 15,693
Provided during the period 606
As at 30 September 2024 16,299
...CONTINUED
Page 2
Page 3
Net Book Value
As at 30 September 2024 272
As at 1 October 2023 878
5. Debtors
2024 2023
£ £
Due within one year
Trade debtors 19,247 6,062
Other debtors - 250
19,247 6,312
6. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 2,973 -
Other creditors 128,029 127,164
Taxation and social security 4,561 3,700
135,563 130,864
Page 3